Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Filed Aug 10, 2018 · 10-Q · 41 days after period end · 0001493152-18-011317
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $301.67K | $307.68K | $379.41K | $286.02K |
| Net Income | -$418.58K | -$360.72K | -$305.36K | -$420.27K |
| EPS Diluted | -$0.02 | -$0.02 | -$0.03 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 10, 2018 · 41 d after period end
